Latest News

Investigational Two-Drug HIV Regimen Shows Minimal Impact on Weight and Lipids in Phase 3 Trials / Image credit:  ©artegorov3@gmail/AdobeStock
Investigational Two-Drug HIV Regimen Shows Minimal Impact on Weight and Lipids in Phase 3 Trials

October 15th 2025

Merck reveals promising phase 3 results for DOR/ISL, showing minimal impact on weight and lipids in adults with suppressed HIV-1.

WHO: 1 in 6 Common Infections Now Drug-Resistant as AMR Threatens Global Health / image credit ©royaltystockphoto/shutterstock.com
WHO: 1 in 6 Common Infections Now Drug-Resistant, AMR Threatens Global Health

October 13th 2025

Measles Outbreak Fails to Push MMR Rates to Herd Immunity Levels /  image credit ©Tryfonov/stock.adobe.com
Measles Outbreak Fails to Push MMR Rates to Herd Immunity Levels, Study Reveals

September 30th 2025

RSV Vaccines Found Safe and Effective Across High-Risk Groups in Cochrane Review
RSV Vaccines Found Safe and Effective Across High-Risk Groups in Cochrane Review

September 29th 2025

US CDC Reports 460% Surge in Deadly Drug-Resistant NDM-CRE Infections
US CDC Reports 460% Surge in Deadly Drug-Resistant NDM-CRE Infections

September 25th 2025

Latest CME Events & Activities

More News

© 2025 MJH Life Sciences

All rights reserved.